Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Jointfol is a branded nutritional supplement developed and marketed by Jointcare Pharmaceuticals. It is an oral combination product containing Methylcobalamin (Vitamin B12), Thiamine (Vitamin B1), Folic Acid, Pyridoxine (Vitamin B6), and Alpha Lipoic Acid. Although the brand name suggests applications in joint or orthopaedic care, the formulation is primarily designed to address nutritional deficiencies, support nerve health, and manage conditions such as diabetic neuropathy and anemia. The B vitamins in the supplement facilitate nerve regeneration and red blood cell production, while alpha lipoic acid serves as an antioxidant to mitigate oxidative damage. The product is currently approved and marketed in India.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Jointfol.